Literature DB >> 12674762

The experimental and clinical study on the effect of curcumin on cell cycle proteins and regulating proteins of apoptosis in acute myelogenous leukemia.

Yan Chen1, Yudan Wu, Jing He, Wenjuan Chen.   

Abstract

To investigate whether the Bcl-2 gene family is involved in modulating mechanism of apoptosis and change of cell cycle protein induced by curcumin in acute myeloid leukemia HL-60 cell line and primary acute myelogenous leukemic cells, the Bcl-2 family member Mcl-1, Bax and Bak and cell cycle proteins including P27kipl, P21wafl, cyclin D3 and pRbp- were selected and their expression detected by SABC immuno-histochemical stain method. The attitude of sub-G1 peak in DNA histogram was determined by FCM. The TUNEL positive cell percentage was identified by terminal deoxynucleotidyl transferase (TdT)-mediated Biotin dUNP end labeling technique. It was found that when HL-60 cells were treated with 25 mumol/L curcumin for 24 h, the expression level of Mcl-1 was down-regulated, but that of Bax and Bak up-regulated time-dependently. There was significant difference in the expression level of Mcl-1, Bax and Bak between the curcumin-treated groups and control group (P < 0.05-0.01). At the same time, curcumin had no effect on progress of cell cycle in primaty acute myelogenous leukemia at newly diagnosis, but could increase the peak of Sub-G1 (P < 0.05), and down-regulate the expression of Mcl-1 and up-regulate the expression of Bax and Bak with the difference being statistically significant. The expression of P27kipl, P21wafl and pRbp- were elevated and that of cyclin D3 decreased in the presence of curcumin. These findings suggested that the Bcl-2 gene family indeed participated in the regulatory process of apoptosis induced by curcumin in HL-60 cells and AML cells. Curcumin can induce apoptosis of primary acute myelogenous leukemic cells and disturb cell cycle progression of HL-60 cells. The mechanism appeared to be mediated by perturbing G0/G1 phases checkpoints which associated with up-regulation of P27kipl, P21wafl and pRbp- expression, and down-regulation of cyclin D3.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12674762     DOI: 10.1007/BF02896768

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  Modulation of cell death in yeast by the Bcl-2 family of proteins.

Authors:  W Tao; C Kurschner; J I Morgan
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

Review 2.  Apoptosis: Bcl-2-related proteins get connected.

Authors:  M D Jacobson
Journal:  Curr Biol       Date:  1997-05-01       Impact factor: 10.834

3.  Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells.

Authors:  M Watabe; K Ito; Y Masuda; S Nakajo; K Nakaya
Journal:  Oncogene       Date:  1998-02-12       Impact factor: 9.867

4.  Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells.

Authors:  M C Jiang; H F Yang-Yen; J K Lin; J J Yen
Journal:  Oncogene       Date:  1996-08-01       Impact factor: 9.867

5.  A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells.

Authors:  K Piwocka; K Zabłocki; M R Wieckowski; J Skierski; I Feiga; J Szopa; N Drela; L Wojtczak; E Sikora
Journal:  Exp Cell Res       Date:  1999-06-15       Impact factor: 3.905

6.  Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin.

Authors:  C Ramachandran; W You
Journal:  Breast Cancer Res Treat       Date:  1999-04       Impact factor: 4.872

7.  Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53.

Authors:  S S Han; S T Chung; D A Robertson; D Ranjan; S Bondada
Journal:  Clin Immunol       Date:  1999-11       Impact factor: 3.969

8.  Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway.

Authors:  R Hanif; L Qiao; S J Shiff; B Rigas
Journal:  J Lab Clin Med       Date:  1997-12

9.  G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.

Authors:  G Juan; B Ardelt; X Li; S M Mikulski; K Shogen; W Ardelt; A Mittelman; Z Darzynkiewicz
Journal:  Leukemia       Date:  1998-08       Impact factor: 11.528

10.  Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells.

Authors:  S H Jee; S C Shen; C R Tseng; H C Chiu; M L Kuo
Journal:  J Invest Dermatol       Date:  1998-10       Impact factor: 8.551

  10 in total
  5 in total

Review 1.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

2.  Cancer-linked targets modulated by curcumin.

Authors:  Noor Hasima; Bharat B Aggarwal
Journal:  Int J Biochem Mol Biol       Date:  2012-12-24

3.  Anti-Apoptotic Effects of Osteopontin via the Up-Regulation of AKT/mTOR/β-Catenin Loop in Acute Myeloid Leukemia Cells.

Authors:  Mahdi Zahed Panah; Mohsen Nikbakht; Seyed Mehdi Sajjadi; Shahrbano Rostami; Amir Hossein Norooznezhad; Hosein Kamranzadeh Fumani; Ardeshir Ghavamzadeh; Saeed Mohammadi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

Review 4.  New insights into therapeutic activity and anticancer properties of curcumin.

Authors:  Abir Kumar Panda; Dwaipayan Chakraborty; Irene Sarkar; Tila Khan; Gaurisankar Sa
Journal:  J Exp Pharmacol       Date:  2017-03-31

5.  Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.

Authors:  Khaled AbouAitah; Anna Swiderska-Sroda; Ahmed A Farghali; Jacek Wojnarowicz; Agata Stefanek; Stanislaw Gierlotka; Agnieszka Opalinska; Abdou K Allayeh; Tomasz Ciach; Witold Lojkowski
Journal:  Oncotarget       Date:  2018-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.